, Volume 176, Issue 5–6, pp 409–415 | Cite as

Six-Year Trend Analysis of Nosocomial Candidemia and Risk factors in Two Intensive Care Hospitals in Mato Grosso, Midwest Region of Brazil

  • Hugo Dias Hoffmann-Santos
  • Claudete Rodrigues Paula
  • Ana Caroline Akeme Yamamoto
  • Tomoko Tadano
  • Rosane C. Hahn


We conducted this cross-sectional retrospective study using clinical and laboratory data from two tertiary hospitals in Cuiabá, Mato Grosso, Brazil, in order to explore the risk factors and estimate mortality, prevalence and lethality of candidemia between 2006 and 2011. A total of 130 episodes of candidemia were identified. The prevalence of candidemia was 1.8 per 1,000 admissions, the mortality rate was 0.9 per 1,000 admissions, and the lethality was 49.2 %. The main agent in this population was Candida parapsilosis (n = 50), followed by C. albicans (n = 45). Comparison between the numbers of episodes in the two triennia revealed that the non-albicans group grew by 48.2 %. The distribution of yeast species of Candida per hospital unit revealed that C. albicans was more prevalent than C. parapsilosis in the adult ICU and C. parapsilosis was more prevalent than C. albicans in the neonatal ICU. Patients remained hospitalized for an average of 53.5 days. Central venous catheters, parenteral nutrition and age were the variables that proved to be independent in the multivariate analysis and that maintained a statistically significant association with the incidence of death in patients with candidemia. The annual prevalence of candidemia showed a significant increase in the second triennium (2009–2011) compared with the first (2006–2008) probably due to increased exposure to risk factors: central venous catheter, H2 blockers, nutrition parenteral corticosteroids and mean hospital duration.


Candida Infection Epidemiology Tertiary care centers Candidemia Brazil 



Cor Jesus Fernandes Fontes, PhD for statistical analysis.


  1. 1.
    Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44:2816–23.PubMedCrossRefGoogle Scholar
  2. 2.
    Ruhnke M, Rickerts V, Cornely OA, et al. Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses. 2011;54:279–310.PubMedCrossRefGoogle Scholar
  3. 3.
    Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for Candida bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis. 2001;33:177–86.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen LY, Liao SY, Kuo SC, et al. Changes in the incidence of candidaemia during 2000–2008 in a tertiary medical centre in northern Taiwan. J Hosp Infect. 2011;78:50–3.PubMedCrossRefGoogle Scholar
  5. 5.
    Garnacho-Montero J, Díaz-Martín A, García-Cabrera G, et al. Risk factors for fluconazol-resistant candidemia. Antimicrob Agents Chemother. 2010;54:3149–54.PubMedCrossRefGoogle Scholar
  6. 6.
    Yamamoto AC, Paula CR, Dias LB, et al. Epidemiological and clinical characteristics of nosocomial candidiasis in university hospitals in Cuiabá-Mato Grosso, Brazil. Rev Iberoam. Micol. 2012;29:164–8.CrossRefGoogle Scholar
  7. 7.
    Cisterna R, Ezpeleta G, Telleria O, et al. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol. 2010;48:4200–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Benjamin DK, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126:e865–73.PubMedCrossRefGoogle Scholar
  9. 9.
    Ortega M, Marco F, Soriano A, et al. Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008. J Hosp Infect. 2011;77:157–61.PubMedCrossRefGoogle Scholar
  10. 10.
    Chang MR, Correia FP, Costa LC, et al. Candida bloodstream infection: data from a teaching hospital in MatoGrosso do Sul, Brazil. Rev Inst Med Trop Sao Paulo. 2008;50:265–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Das I, Nightingale P, Patel M, Jumaa P. Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK. Int J Infect Dis. 2011;15:e759–63.PubMedCrossRefGoogle Scholar
  12. 12.
    Colombo AL, Guimarães T, Silva LRBF, et al. Prospective observational study of candidemia in São Paulo, Brazil: Incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol. 2007;28:570–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Camargo TZS, Marra AR, Silva CV, et al. Secular trends of candidemia in a tertiary care hospital. Am J Infect Control. 2010;38:546–50.PubMedCrossRefGoogle Scholar
  14. 14.
    Chaiwarith R, Ounbang P, Khamwan C, et al. Epidemiology of adult candidemia at Chiang Mai University Hospital. Southeast Asian J Trop Med Public Health. 2011;42:1505–14.PubMedGoogle Scholar
  15. 15.
    Ylipalosaari P, Ala-Kokko TI, Karhu J, et al. Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment. Crit Care. 2012;16:1–9.CrossRefGoogle Scholar
  16. 16.
    Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695–703.PubMedCrossRefGoogle Scholar
  17. 17.
    Bruder-Nascimento A, Camargo CH, Sugizaki MF, et al. Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital. BMC Res Notes. 2010;3:1–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis. 2010;51:561–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51:e38–45.PubMedCrossRefGoogle Scholar
  20. 20.
    Tumbarello M, Fiori B, Trecarichi EM, et al. Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PLoS ONE. 2012;7:1–9.Google Scholar
  21. 21.
    De Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of clinical fungi. 2011. 2th [electronic version 3.1] ISBN/EAN: 978-90-70351-65-6.Google Scholar
  22. 22.
    Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37:1172–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Richet H, Roux P, Des Champs C, et al. Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect. 2002;8:405–12.PubMedCrossRefGoogle Scholar
  24. 24.
    Fortún J, Martín-Dávila P, Pedrosa EGG, et al. Emerging trends in candidemia: a higher incidence but a similar outcome. J Infect. 2012;65:64–70.PubMedCrossRefGoogle Scholar
  25. 25.
    França JCB, Ribeiro CEL, Queiroz-Telles F. Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility. Rev Soc Bras Med Trop. 2008;41:23–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Gómez J, García-Vázquez E, Espinosa C, et al. Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts. Rev Iberoam Micol. 2009;26:184–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Ajenjo MCH, Aquevedo AS, Guzmán AMD, et al. Epidemiological profile of invasive candidiasis in intensive care units at a university hospital. Rev Chilena Infectol. 2011;28:118–22.CrossRefGoogle Scholar
  28. 28.
    Chalmers C, Gaur S, Chew J, et al. Epidemiology and management of candidaemia: a retrospective, multicentre study in five hospitals in the UK. Mycoses. 2011;54:e795–800.PubMedCrossRefGoogle Scholar
  29. 29.
    Bassetti M, Taramasso L, Nicco E, et al. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE. 2011;6:1–6.CrossRefGoogle Scholar
  30. 30.
    Nucci M, Colombo AL. Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis. 2007;58:77–82.PubMedCrossRefGoogle Scholar
  31. 31.
    Hinrichsen SL, Falcão E, Vilella TAS, et al. Candidemia in a tertiary hospital in northeastern Brazil. Rev Soc Bras Med Trop. 2008;41:394–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Ghahri M, Mirhendi H, Fooladi AAI, Beyraghi S. Species identification of candida strains isolated from patients with candidemia, hospitalized in Tehran, by enzymatic digestion of ITS-rDNA. J Isfaham Med School. 2012;29. Accessed 30 Jan. 2013.
  33. 33.
    Medrano DJA, Brilhante RSN, Cordeiro RA, et al. Candidemia in a Brazilian hospital: the importance of Candida parapsilosis. Rev Inst Med Trop Sao Paulo. 2006;48:17–20.PubMedCrossRefGoogle Scholar
  34. 34.
    Nucci M, Silveira MI, Spector N, et al. Fungemia in cancer patients in Brazil: predominance of non-albicans species. Mycopathologia. 1998;141:65–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Ha YE, Peck KR, Joo EJ, et al. Impact of first-line antifungal agents on the outcomes and costs of candidemia. Antim Agents Chemother. 2012. Accessed 30 Jan. 2013.
  36. 36.
    Nucci M, Queiroz-Telles F, Alvarado-Matute T, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS ONE. 2013;8:e59373.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Hugo Dias Hoffmann-Santos
    • 1
  • Claudete Rodrigues Paula
    • 2
  • Ana Caroline Akeme Yamamoto
    • 1
  • Tomoko Tadano
    • 3
  • Rosane C. Hahn
    • 1
  1. 1.Laboratório de Micologia, Faculdade de MedicinaUniversidade Federal de Mato GrossoCuiabáBrazil
  2. 2.Faculdade de OdontologiaUniversidade de São Paulo (USP)São PauloBrazil
  3. 3.Laboratório de Micologia, Hospital Universitário Júlio MullerUniversidade Federal de Mato GrossoCuiabáBrazil

Personalised recommendations